Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

per Micallef, Ivana N. M., Maurer, Matthew J., Wiseman, Gregory A., Nikcevich, Daniel A., Kurtin, Paul J., Cannon, Michael W., Perez, Domingo G., Soori, Gamini S., Link, Brian K., Habermann, Thomas M., Witzig, Thomas E.
Publicat 2011

Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group

per WITZIG, THOMAS E., GEYER, SUSAN M., KURTIN, PAUL J., COLGAN, JOSEPH P., INWARDS, DAVID J., MICALLEF, IVANA N. M., LaPLANT, BETSY R., MICHALAK, JOHN C., SALIM, MUHAMMAD, DALTON, ROBERT J., MOORE, DENNIS F., REEDER, CRAIG B.
Publicat 2008

Elevated Monoclonal and Polyclonal Serum Immunoglobulin Free Light Chain (FLC) as Prognostic Factors in B- and T-cell Non-Hodgkin Lymphoma

per Witzig, Thomas E., Maurer, Matthew J., Habermann, Thomas M., Link, Brian K., Micallef, Ivana N. M., Nowakowski, Grzegorz S., Ansell, Stephen M., Colgan, Joseph P., Inwards, David J., Porrata, Luis F., Markovic, Svetomir N., Johnston, Patrick B., Lin, Yi, Thompson, Carrie, Gupta, Mamta, Katzmann, Jerry A., Cerhan, James R.
Publicat a Am J Hematol (2014)

Elevated Serum Free Light Chains Are Associated With Event-Free and Overall Survival in Two Independent Cohorts of Patients With Diffuse Large B-Cell Lymphoma

per Maurer, Matthew J., Micallef, Ivana N.M., Cerhan, James R., Katzmann, Jerry A., Link, Brian K., Colgan, Joseph P., Habermann, Thomas M., Inwards, David J., Markovic, Svetomir N., Ansell, Stephen M., Porrata, Luis F., Johnston, Patrick B., Nowakowski, Grzegorz S., Thompson, Carrie A., Gupta, Mamta, Syrbu, Sergei I., Kurtin, Paul J., Macon, William R., Nikcevich, Daniel A., Witzig, Thomas E.
Publicat 2011

A Phase I Trial of Immunostimulatory CpG 7909 Oligodeoxynucleotide and (90)Yttrium Ibritumomab Tiuxetan Radioimmunotherapy for Relapsed B-cell Non-Hodgkin Lymphoma

per Witzig, Thomas E., Wiseman, Gregory A., Maurer, Matthew J., Habermann, Thomas M., Micallef, Ivana N. M., Nowakowski, Grzegorz S., Ansell, Stephen M., Colgan, Joseph P., Inwards, David J., Porrata, Luis F., Link, Brian K., Zent, Clive S., Johnston, Patrick B., Shanafelt, Tait D., Allmer, Cristine, Asmann, Yan W., Gupta, Mamta, Ballas, Zuhair K., Smith, Brian J., Weiner, George J.
Publicat 2013

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

per Witzig, Thomas E., Tang, Hui, Micallef, Ivana N. M., Ansell, Stephen M., Link, Brian K., Inwards, David J., Porrata, Luis F., Johnston, Patrick B., Colgan, Joseph P., Markovic, Svetomir N., Nowakowski, Grzegorz S., Thompson, Carrie A., Allmer, Cristine, Maurer, Matthew J., Gupta, Mamta, Weiner, George, Hohl, Ray, Kurtin, Paul J., Ding, Husheng, Loegering, David, Schneider, Paula, Peterson, Kevin, Habermann, Thomas M., Kaufmann, Scott H.
Publicat 2011

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines

per Ansell, Stephen M., Kyle, Robert A., Reeder, Craig B., Fonseca, Rafael, Mikhael, Joseph R., Morice, William G., Bergsagel, P. Leif, Buadi, Francis K., Colgan, Joseph P., Dingli, David, Dispenzieri, Angela, Greipp, Philip R., Habermann, Thomas M., Hayman, Suzanne R., Inwards, David J., Johnston, Patrick B., Kumar, Shaji K., Lacy, Martha Q., Lust, John A., Markovic, Svetomir N., Micallef, Ivana N. M., Nowakowski, Grzegorz S., Porrata, Luis F., Roy, Vivek, Russell, Stephen J., Short, Kristen E. Detweiler, Stewart, A. Keith, Thompson, Carrie A., Witzig, Thomas E., Zeldenrust, Steven R., Dalton, Robert J., Rajkumar, S. Vincent, Gertz, Morie A.
Publicat 2010